HPC Biosciences [HPBL] vs Aro Granite [AGI] Detailed Stock Comparison

HPC Biosciences Ltd.

BSE
Loading...

Aro Granite Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: HPC Biosciences Ltd. wins in 6 metrics, Aro Granite Industries Ltd. wins in 13 metrics, with 0 ties. Aro Granite Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric HPC Biosciences Ltd. Aro Granite Industries Ltd. Better
P/E Ratio (TTM) 9.38 11.03 HPC Biosciences Ltd.
Price-to-Book Ratio 2.55 1.65 Aro Granite Industries Ltd.
Debt-to-Equity Ratio 219.28 20.88 Aro Granite Industries Ltd.
PEG Ratio 0.03 -12.29 HPC Biosciences Ltd.
EV/EBITDA 8.34 6.45 Aro Granite Industries Ltd.
Profit Margin (TTM) 3.53% 12.67% Aro Granite Industries Ltd.
Operating Margin (TTM) 14.19% 16.82% Aro Granite Industries Ltd.
EBITDA Margin (TTM) 14.19% 16.82% Aro Granite Industries Ltd.
Return on Equity 12.16% 15.37% Aro Granite Industries Ltd.
Return on Assets (TTM) 3.38% 9.22% Aro Granite Industries Ltd.
Free Cash Flow (TTM) $-189.52M $1.75B Aro Granite Industries Ltd.
Dividend Yield N/A 1.38% N/A
1-Year Return 42.25% -29.95% HPC Biosciences Ltd.
Price-to-Sales Ratio (TTM) 0.38 1.40 HPC Biosciences Ltd.
Enterprise Value $4.40B $41.01B Aro Granite Industries Ltd.
EV/Revenue Ratio 0.78 1.56 HPC Biosciences Ltd.
Gross Profit Margin (TTM) 48.80% 72.99% Aro Granite Industries Ltd.
Revenue per Share (TTM) $434 $406 HPC Biosciences Ltd.
Earnings per Share (Diluted) $21.73 $51.43 Aro Granite Industries Ltd.
Beta (Stock Volatility) -0.01 -0.39 Aro Granite Industries Ltd.

HPC Biosciences Ltd. vs Aro Granite Industries Ltd. Stock Performance Analysis

Loading Price Chart...

HPBL
AGI

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
HPC Biosciences Ltd.-0.80%-8.93%-12.73%34.39%24.06%36.37%
Aro Granite Industries Ltd.-0.16%4.00%-3.52%17.19%-19.93%-18.87%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
HPC Biosciences Ltd.42.25%-0.26%-59.52%-59.52%-59.52%-59.52%
Aro Granite Industries Ltd.-29.95%0.26%158.81%691.77%1,175.57%1,668.44%

Performance & Financial Health Analysis: HPC Biosciences Ltd. vs Aro Granite Industries Ltd.

MetricHPBLAGI
Market Information
Market Cap i₹2.17B₹36.18B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i9,116211,648
90 Day Avg. Volume i5,708243,518
Last Close₹248.00₹610.35
52 Week Range₹140.10 - ₹284.45₹465.00 - ₹1,009.00
% from 52W High-12.81%-39.51%
All-Time High₹704.50 (Jan 17, 2022)₹1,307.90 (Dec 16, 2024)
% from All-Time High-64.80%-53.33%
Growth Metrics
Quarterly Revenue Growth0.02%-0.04%
Quarterly Earnings Growth3.27%-0.21%
Financial Health
Profit Margin (TTM) i0.04%0.13%
Operating Margin (TTM) i0.14%0.17%
Return on Equity (TTM) i0.12%0.15%
Debt to Equity (MRQ) i219.2820.88
Cash & Liquidity
Book Value per Share (MRQ)₹79.86₹342.86
Cash per Share (MRQ)₹1.91₹2.44
Operating Cash Flow (TTM) i₹-217,642,000₹4.35B
Levered Free Cash Flow (TTM) i₹96.26M₹3.22B
Dividends
Last 12-Month Dividend Yield iN/A1.38%
Last 12-Month Dividend iN/A₹13.00

Valuation & Enterprise Metrics Analysis: HPC Biosciences Ltd. vs Aro Granite Industries Ltd.

MetricHPBL (Apr 24, 2026)AGI (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i9.3811.03
Forward P/E iN/A8.89
PEG Ratio i0.03-12.29
Price to Sales (TTM) i0.381.40
Price to Book (MRQ) i2.551.65
Market Capitalization
Market Capitalization i₹2.17B₹36.18B
Enterprise Value i₹4.40B₹41.01B
Enterprise Value Metrics
Enterprise to Revenue i0.781.56
Enterprise to EBITDA i8.346.45
Risk & Other Metrics
Beta i-0.01-0.39
Book Value per Share (MRQ) i₹79.86₹342.86

Financial Statements Comparison: HPC Biosciences Ltd. vs Aro Granite Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricHPBL (2025)AGI (2025)
Revenue/Sales i4.61B25.29B
Cost of Goods Sold i3.93B10.31B
COGS % of Revenue i85.2%40.8%
Gross Profit i680.37M14.98B
Gross Margin i14.8%59.2%
Research & Development iN/AN/A
Operating Income (EBIT) i300.06M4.59B
Operating Margin i6.5%18.2%
EBITDA i386.57M6.61B
EBITDA Margin i8.4%26.1%
Pre-Tax Income i195.76M4.27B
Pre-Tax Income % of Revenue i4.2%16.9%
Income Tax i46.49M1.04B
Income Tax % of Revenue i1.0%4.1%
Net Income (Profit) i133.31M3.22B
Profit Margin i2.9%12.7%

Balance Sheet & Liquidity Metrics

MetricHPBL (2025)AGI (2025)
Cash & Equivalents i7.79M280.21M
Total Current Assets i1.80B12.72B
Total Current Assets % of Revenue i39.0%50.3%
Total Current Liabilities i1.70B7.43B
Total Current Liabilities % of Revenue i36.9%29.4%
Long-Term Debt i324.35M3.79B
Long-Term Debt % of Revenue i7.0%15.0%
Total Shareholders Equity i791.64M20.98B
Retained Earnings i-337.75M14.32B
Retained Earnings % of Revenue i-7.3%56.6%
Property, Plant & Equipment i80.41M62.57M

Cash Flow Statement Comparison

MetricHPBL (2025)AGI (2025)
Operating Cash Flow i-217.64M4.35B
Operating Cash Flow % of Revenue i-4.7%17.2%
Capital Expenditures i2.99M-2.47B
Free Cash Flow i-189.52M1.75B
FCF Margin i-4.1%6.9%
Debt Repayment i-151.53M-1.19B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricHPBLAGI
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.67M64.70M
Float Shares i1.06M18.76M
% Held by Insiders i92.61%70.74%
% Held by Institutions i0.00%2.68%
% Held by Public i7.39%26.58%

Dividend Analysis & Yield Comparison: HPC Biosciences Ltd. vs Aro Granite Industries Ltd.

MetricHPBLAGI
Last 12-Month Dividend iN/A₹13.00
Last 12-Month Dividend Yield iN/A1.38%
3-Year Avg Annual Dividend iN/A₹7.67
3-Year Avg Dividend Yield iN/A0.87%
3-Year Total Dividends iN/A₹23.00
Ex-Dividend DateN/AAug 22, 2025